ClinicalTrials.Veeva

Menu

Histologic Comparison of Ablative Techniques for Endometriosis

TriHealth logo

TriHealth

Status

Enrolling

Conditions

Endometriosis Pelvic
Endometriosis-related Pain
Endometriosis
Endometriosis; Peritoneum

Treatments

Device: Argon Beam Coagulator
Device: CO2 Laser
Device: Diathermy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To our knowledge, no other human studies directly compare the effectiveness of the various ablative technologies. We set out to design a study to directly compare ablative energy sources and evaluate their ability to destroy native endometriosis tissue in humans.

Enrollment

141 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult women 18 years of age or older
  • Already planning to undergo scheduled robotic assisted or laparoscopic excision of lesions for pelvic pain symptoms (pelvic pain, dysmenorrhea, dyspareunia, dysuria, dyschezia, ovarian pain) or endometriosis of any kind (endometriosis of any location, or endometrioma)

Exclusion criteria

  • Known pregnancy at enrollment or at the time of the excision surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

141 participants in 3 patient groups

Diathermy
Active Comparator group
Treatment:
Device: Diathermy
CO2 Laser
Active Comparator group
Treatment:
Device: CO2 Laser
Argon Beam Coagulator
Active Comparator group
Treatment:
Device: Argon Beam Coagulator

Trial contacts and locations

1

Loading...

Central trial contact

Devin Namaky, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems